Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score >2): a retrospective cohort study
Nephrology Dialysis Transplantation · 2023
DOI: 10.1093/ndt/gfac178 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Nephrology Dialysis Transplantation, 2023. Verfasst von Dominique Bertrand und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Kidney Transplantation and Hemodialysis, Rouen University Hospital, Rouen, France. Hauptthemen laut MEDLINE: Immunosuppressive Agents, Kidney Transplantation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Background
Immunosuppression in kidney transplant recipients with decreased graft function and histological vascular changes can be particularly challenging. The impact of a late rescue conversion to belatacept on kidney graft survival in this context has never been studied.
Methods
We report a bicentric retrospective cohort study comparing a calcineurin inhibitor (CNI) to belatacept switch versus CNI continuation in 139 kidney transplant recipients with histological kidney vascular damage (cv ≥2, g + cpt ≤1, i + t ≤1) and low estimated glomerular filtration rate (≤40 mL/min/1.73 m²). Primary outcome was death-censored graft survival.
Results
During the study follow-up, 10 graft losses (14.5%) occurred in the belatacept group (n = 69) versus 26 (37.1%) in the matched CNI group (n = 70) (P = .005). Death-censored graft survival was significantly higher in the belatacept group (P = .001). At 3 years, graft survival was 84.0% in the belatacept group compared with 65.1% in the control group. Continuing CNI was an independent risk factor for graft loss [hazard ratio (HR) 3.46; P < .005]. The incidence of cellular rejection after the conversion was low (4.3% in both groups) and not significantly different between groups (P = .84). Patients switched to belatacept developed significantly less donor-specific antibodies de novo. Belatacept was an independent risk factor for the occurrence of opportunistic infections (HR 4.84; P < .005).
Conclusion
The replacement of CNI with belatacept in patients with decreased allograft function and vascular lesions is associated with an improvement in graft survival and represents a valuable option in a context of organ shortage. Caution should be exercised regarding the increased risk of opportunistic infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Kidney Transplantation and Hemodialysis, Rouen University Hospital, Rouen, France.
- Nephrology and Transplantation Department, Cancerology-Immunity-Transplantation-Infectiology, Clinical Investigation Center-Biotherapies, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, INSERM U955, Paris-…
- Department of Pathology, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Paris-Est-Créteil University, Paris, France.
- Department of Pathology, CHU Rouen, Rouen, France.
- INSERM U1096, Normandie Univ, UNIROUEN, Rouen, France.
ORCID-Profile: Antoine Morel, Tristan de Nattes, Anissa Moktefi, Dominique Guerrot
Zitieren
APA
Bertrand, D., Matignon, M., Morel, A., Ludivine, L., Lemoine, M., Hanoy, M., Roy, F. L., Nezam, D., Hamzaoui, M., de Nattes, T., Moktefi, A., François, A., Laurent, C., Etienne, I., & Guerrot, D. (2023). Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score >2): a retrospective cohort study. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfac178
Vancouver
Bertrand D, Matignon M, Morel A, Ludivine L, Lemoine M, Hanoy M, et al. Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score >2): a retrospective cohort study. Nephrology Dialysis Transplantation. 2023. doi:10.1093/ndt/gfac178
BibTeX
@article{Bertrand2023,
author = {Bertrand, Dominique and Matignon, Marie and Morel, Antoine and Ludivine, Lebourg and Lemoine, Mathilde and Hanoy, Mélanie and Roy, Frank Le and Nezam, Dorian and Hamzaoui, Mouad and de Nattes, Tristan and Moktefi, Anissa and François, Arnaud and Laurent, Charlotte and Etienne, Isabelle and Guerrot, Dominique},
title = {Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score >2): a retrospective cohort study},
journal = {Nephrology Dialysis Transplantation},
year = {2023},
doi = {10.1093/ndt/gfac178}
}
EUVIMED